By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health has awarded $110 million to fund the second phase of its Knockout Mouse Project (KOMP), an initiative to create a disease research resource that in its first phase created knockout mouse embryonic stem cell lines for the roughly 21,000 coding genes in the mouse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.